Nuvectis Pharma, Inc.
NVCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001875558
No open-market purchases or sales by Nuvectis Pharma, Inc. insiders were filed in the last 90 days; 82 institutions reported holding it in 13F filings for Q2 2026, worth $189.0M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Nuvectis Pharma, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 47 | 53 | +6 |
| Shares | 3.24M | 3.69M | +452.1K (+13.9%) |
| Value | $24.2M | $22.2M | −$1.97M (−8.1%) |
New holders (11)
Institutions that held Nuvectis Pharma, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Occam Crest Management LP | 290,000 | $1.75M | 1.19% |
| Goldman Sachs Group Inc | 45,163 | $271.9K | 0.00% |
| Jane Street Group, LLC | 26,278 | $158.2K | 0.00% |
| XTX Topco Ltd | 14,866 | $89.5K | 0.00% |
| Avalon Trust Co | 10,000 | $60.2K | 0.00% |
| Tower Research Capital LLC (TRC) | 3,849 | $23.2K | 0.00% |
| Russell Investments Group, Ltd. | 1,066 | $6.42K | 0.00% |
| GAMMA Investing LLC | 88 | $530 | 0.00% |
| The PNC Financial Services Group, Inc. | 55 | $331 | 0.00% |
| SRS Capital Advisors, Inc. | 38 | $229 | 0.00% |
| CWM, LLC | 35 | $0 | 0.00% |
Sold out (5)
Institutions that held Nuvectis Pharma, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Millennium Management LLC | 31,167 | $232.8K |
| Baxter Bros Inc | 15,000 | $112.0K |
| Marex Group plc | 15,000 | $112.0K |
| Simplex Trading, LLC | 2,114 | $15.0K |
| Avion Wealth | 56 | $0 |